期刊文献+

血清PSA系列在前列腺疾病中的应用 被引量:14

Study on a series of prostate-specific antigen molecules for diagnosis of prostate cancer
下载PDF
导出
摘要 目的探讨血清前列腺特异抗原(PSA)系列在前列腺疾病的诊断与鉴别中的价值.方法用磁微粒子免疫化学发光法测定210例良性前列腺增生(BHP)和138例前列腺癌(PCa)患者血清PSA系列:t-PSA、f-PSA、结合PSA(c-PSA),计算f-PSA/t-PSA、c-PSA/t-PSA、f-PSA/c-PSA的比值.结果 PSA各分子水平在BPH和PCa中变化幅度较大,各比值则较稳定(组内P>0.05),尤其是c-PSA/t-PSA.t-PSA和c-PSA/t-PSA在BPH和pCa患者不同区段上分布差异有显著性(χ2=86.15,P<0.005);在t-PSA诊断灰值区(t-PSA在4.0~10.0 ng/ml),以c-PSA/t-PSA=0.78为界值联合t-PSA可以更有效地区分BPH和PCa.以t-PSA≤10.0 ng/ml和c-PSA/t-PSA≥0.78为界值联合对BPH和PCa进行筛选,敏感性为95.8%,特异性为97.3%,阴性预测值为83.6%,阳性预测值为96.8%.结论 t-PSA与c-PSA/t-PSA的联合应用,对前列腺疾病的诊断具有重要临床意义,尤其是在t-PSA的诊断灰值区. Objective To evaluate the series of prostate-specific antigen (PSA) molecules in serum,i.e.,total PSA (t-PSA),free-PSA (f-PSA) and complexed-PSA(c-PSA),for the diagnosis of prostate diseases.Methods Serum samples were obtained from 210 men with untreated benign prostatic hyperplasia (BPH) and 138 men with untreated prostate cancer (PCa).The levels of c-PSA,f-PSA,t-PSA in serum were determined by auto-immunochemical luminescence method,and the ratio of f-PSA/t-PSA,c-PSA/t-PSA and f-PSA/c-PSA were calculated.Results The range of c-PSA,f-PSA and t-PSA levels were significiantly changed in both BPH and Pca groups,but the ratio of f-PSA/t-PSA,f-PSA/c-PSA,especially c-PSA/t-PSA were relatively invariant ( P >0.05).There was a significant difference in the distribution of t-PSA and c-PSA/t-PSA ratio in both the patients with PCa and BPH (χ2=86.15, P <0.005).In the diagnostic gray zone of t-PSA (t-PSA values between 4.0 ng/ml and 10.0 ng/ml) the combination of t-PSA with c-PSA/t-PSA was helpful for effectively differentiation of PCa from BPH.When t-PSA≤10.0ng/ml and c-PSA/t-PSA≥0.78 was taken as the cut-off value for the screening of PCa,the sensitivity,specificity,negative predictive value and positive predictive value were 95.8%,97.3%,83.6% and 96.8% respectively.Conclusions The levels of the series of PSA molecules (c-PSA,f-PSA,t-PSA) in serum,especially c-PSA and c-PSA/t-PSA ratio hold important clinical significance for the early diagnosis of prostate diseases and the assessment for Pca,and it should be more sensitive and reliable especially within the diagnostic gray zone of t-PSA.
出处 《临床检验杂志》 CAS CSCD 北大核心 2005年第2期137-138,共2页 Chinese Journal of Clinical Laboratory Science
关键词 F-PSA 诊断 BPH 前列腺疾病 血清PSA 患者 联合 PC A系列 显著性 prostate cancer prostate-specific antigen benign prostatic hyperplasia
  • 相关文献

参考文献4

  • 1杨振华.检验项目的临床性能——如何判断检验的临床准确性[J].临床检验杂志,2002,20(U08):120-126. 被引量:3
  • 2Jung K,Elgeti U,Lein M,et al.Ratio of free or comlexed prostate-specific antigen to total PSA:which ratio improves differentiation between benign prosatic hyperplasia and prostate cancer[J]?Clinal Chem,2000,46(1):55~62.
  • 3Lein M,Jung K,Elgeti U,et al.Comparison of the clinical validity of free prostate-spcific antigen,alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis[J].Eur Urol,2001,39(1):57~64.
  • 4Jung K,Stephan C,Elgeti U,et al.Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen<4 microg/L:are they useful tools for early detection and screening of prostate cancer[J]?Int J Cancer,2001,93(5):759~765.

共引文献2

同被引文献70

引证文献14

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部